Ipsogen prices IPO

Molecular diagnostic company Ipsogen (Euronext:ALIPS) raised EUR 11.8 million ($18.7 million) through the sale of 1.6 million shares at EUR 7.20 in an IPO on Euronext Paris' Alternext market. The deal...